Explore how breast cancer stem cell plasticity, epigenetic reprogramming, and single-cell insights drive therapy resistance, revealing new targets to improve durable responses.
Nejina Rijal
Advertisement
Articles by Nejina Rijal
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Atezolizumab/Chemo Earns FDA Priority Review in Stage III dMMR/MSI-H Colon Cancer
2
69 Assessing the Impact and Efficacy of Anthracyclines and Trastuzumab Alternatives on Potential Cardiotoxicity in Breast Cancer Patients
3
CD20×CD3 Bispecific Antibodies May Be Feasible Bridging Strategy in LBCL
4
Blinatumomab Substitution Improves EFS in Pediatric High-Risk B-ALL
5